Vertex Pharmaceuticals
VRTX
#180
Rank
C$157.40 B
Marketcap
C$613.92
Share price
1.75%
Change (1 day)
-7.69%
Change (1 year)

Earnings for Vertex Pharmaceuticals (VRTX)

Earnings in 2025 (TTM): C$6.25 Billion

According to Vertex Pharmaceuticals's latest financial reports the company's current earnings are C$11.72 Billion. In 2024 the company made an earning of C$0.38 Billion a decrease over its 2023 earnings that were of C$6.10 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Vertex Pharmaceuticals from 1990 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) C$6.25 B1522.87%
2024 C$0.38 B-93.69%
2023 C$6.10 B3.19%
2022 C$5.91 B53.56%
2021 C$3.85 B-12.06%
2020 C$4.38 B118.45%
2019 C$2.00 B120.64%
2018 C$0.90 B1473.64%
2017 C$57.79 M197.6%
2016 C$19.42 M-102.97%
2015 -C$0.66 Billion-28.46%
2014 -C$0.92 Billion-51.5%
2013 -C$1.89 Billion-30584.68%
2012 C$6.18 M-95.47%
2011 C$0.13 B
2009 -C$0.82 Billion
2007 -C$0.57 Billion83.1%
2006 -C$0.32 Billion59.02%
2005 -C$0.2 Billion3.28%
2004 -C$0.19 Billion-38.16%
2003 -C$0.31 Billion
2000 -C$52.53 Million-20.38%
1999 -C$65.97 Million31.62%
1998 -C$50.13 Million91.05%
1997 -C$26.24 Million-36.24%
1996 -C$41.15 Million12.45%
1995 -C$36.59 Million27.4%
1994 -C$28.72 Million-1833.33%
1993 C$1.65 M-112.12%
1992 -C$13.67 Million175%
1991 -C$4.98 Million-12.2%
1990 -C$5.67 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Gilead Sciences
GILD
C$13.64 B 121.58%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
C$2.29 B-62.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
C$31.88 B 417.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$11.09 B 80.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
C$44.72 B 626.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Enanta Pharmaceuticals
ENTA
-C$0.12 Billion-101.93%๐Ÿ‡บ๐Ÿ‡ธ USA